HIV/AIDS Treatment Trends and Progress: Where Do We Stand Today?
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Address: PO Box 651761
Tel: +27 11 777 7500
SAMED’s mission is to safeguard and promote the interests of our members, to encourage ethical principles and practices, promote innovation and better patient outcomes and ensure effective representation with all relevant authorities whether public or private.
Objectives of the association include:
Ensuring that all activities of the company shall have the best interests of its members as the primary objective, provided that such shall not unreasonably diminish from the needs and rights of patients;
Providing a forum for discussion on matters affecting the manufacturers and distributors of medical and surgical products in South Africa;
Promoting and encouraging among members ethical principles and practices, voluntarily agreed upon, and to this end, publish a Code of Business Practice which shall be binding on all members;
Communicate and represent, through an elected committee of members, the industry’s standpoint on relevant matters and offer advice or make recommendations when the need arises to any body or institution whose decisions and policies might affect the industry;
Co-operating with governments and regulatory authorities, whether national or international, as appropriate;
Working towards harmonization of standards and regulatory requirements within the area of medical devices manufacture and supply;
and Promoting a spirit of co-operation and shared responsibility among public and private health care professionals and providers, which shall include the State, as well as other relevant sectors, within the context of effective, efficient and transparent health care delivery.
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
Lenias Hwenda of Medicines for Africa examines the true impact of access to medicine initiatives in Africa, noting that many of the measures takes are often cosmetic and leave a…
Some of the top pharma news coming out of South Africa including Afrigen’s partnership with US National Institutes of Health (NIH), BioNTech’s efforts to bring an mRNA start-to-finish vaccine manufacturing network…
See our Cookie Privacy Policy Here
